reported that high CX3CL1 expression was detected in 33.3% of primary invasive cancers and that CX3CL1 expression correlated positively with increased tumor-infiltrating lymphocytes (TILs; P=0.005). The gene discussed is CX3CL1; the disease is neoplasm.